Recruiting
Homocystinuria
RecruitingA study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
Investigational
A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
Investigational
- Disease:Homocystinuria
- Substances:Pegtibatinase
Countries:
Belgium
Belgium- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Pegtibatinase
- Sponsor:Travere Therapeutics Inc.



